Treatment of Allergic Rhinitis
Intranasal corticosteroids are the most effective medication class for controlling allergic rhinitis symptoms and should be considered first-line therapy for moderate to severe cases. 1
Diagnosis and Clinical Presentation
Allergic rhinitis typically presents with:
- Nasal congestion
- Rhinorrhea (runny nose)
- Sneezing
- Itching of the nose, eyes, and throat 2
Physical examination may reveal:
- Edematous and pale turbinates (seasonal allergic rhinitis)
- Erythematous and inflamed turbinates with serous secretions (perennial allergic rhinitis) 2
Treatment Algorithm
First-Line Treatment Options:
For Mild Intermittent or Mild Persistent Allergic Rhinitis:
For Moderate to Severe Persistent Allergic Rhinitis:
Environmental Control Measures:
- Identify and avoid allergen triggers (pollens, fungi, dust mites, animal dander) 1
- For pollen allergies: limit outdoor exposure during high pollen counts 1
- For dust mite allergies: use dust mite covers for bedding, HEPA vacuuming, humidity control 1
- For animal allergies: avoidance is most effective 1
- For indoor fungi: remove moisture sources and use dilute bleach on non-porous surfaces 1
Medication Details
Intranasal Corticosteroids:
- Most effective for controlling all symptoms including nasal congestion 1
- Work by acting on multiple inflammatory substances (histamine, prostaglandins, cytokines, tryptases, chemokines, leukotrienes) 3
- May take several days to reach maximum effect; best used regularly once daily 3
- Minimal systemic side effects at recommended doses 1
- Local side effects may include nasal irritation and bleeding 1
Second-Generation Antihistamines:
- Preferred over first-generation antihistamines due to less sedation and fewer anticholinergic effects 1, 4
- Effective for rhinorrhea, sneezing, and itching but less effective for nasal congestion 2
- Differences in sedative properties:
- Fexofenadine, loratadine, and desloratadine do not cause sedation at recommended doses
- Loratadine and desloratadine may cause sedation at higher doses
- Cetirizine may cause sedation at recommended doses 1
Intranasal Antihistamines:
- May be used as first-line treatment for allergic and nonallergic rhinitis 1
- Equal to or superior to oral second-generation antihistamines for seasonal allergic rhinitis 1
- Can have a clinically significant effect on nasal congestion 1
- Generally less effective than intranasal corticosteroids 1
Combination Therapy:
- For moderate to severe symptoms, combination of intranasal corticosteroid and intranasal antihistamine may be more effective than either agent alone 1
Other Treatment Options:
- Leukotriene receptor antagonists (montelukast) can be useful but are less effective than intranasal corticosteroids 1
- Intranasal cromolyn sodium is effective for some patients but less effective than corticosteroids 1
- Nasal saline is beneficial for chronic rhinorrhea and rhinosinusitis 1
- Oral decongestants (pseudoephedrine, phenylephrine) can reduce nasal congestion but may cause side effects like insomnia, irritability, and palpitations 1
- Intranasal anticholinergics (ipratropium) may effectively reduce rhinorrhea but have no effect on other symptoms 1
Special Considerations
Pitfalls to Avoid:
- Using first-generation antihistamines which cause significant sedation, performance impairment, and anticholinergic effects 1, 4
- Using topical decongestants for more than 3 days (risk of rhinitis medicamentosa) 1
- Single or recurrent administration of parenteral corticosteroids (contraindicated due to potential long-term side effects) 1
- Failing to consider comorbid conditions like asthma, sinusitis, and sleep apnea 1
For Children (Ages 4-11):
- Lower dose of intranasal corticosteroids
- Limited to 2 months of use per year before consulting a doctor (concerns about potential growth effects) 3
For Severe or Intractable Symptoms:
- A short course (5-7 days) of oral corticosteroids may be appropriate 1
- Allergen immunotherapy should be considered for patients with specific IgE antibodies to clinically relevant allergens who have inadequate response to medications 1